Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05103384 · ClinicalTrials.gov registry record
Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 15
- Enrollment target
NCT05103384: Completed study, sponsored by The Cleveland Clinic.
NCT05103384 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05103384 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
The project uses virtual reality technology to recreate situations that cause freezing of gait in individuals with Parkinson's disease. Individuals who underwent deep brain stimulator (DBS) surgery for Parkinson's disease will walk through a virtual reality environment while brain signals are recorded from the DBS device. The goal is to better understand what occurs in the brain during freezing of gait.
Primary Outcome
Number of freezing of gait episodes
Interventions
- OTHER Virtual Reality Environment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2024-06-24 |
What the finished NCT05103384 record still lists
NCT05103384 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Virtual Reality Environment is the first listed.
NCT05103384 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05103384 about?
NCT05103384 is a clinical study titled "Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming". The project uses virtual reality technology to recreate situations that cause freezing of gait in individuals with Parkinson's disease. Individuals who underwent deep brain stimulator (DBS) surgery for Parkinson's disease will walk through a virtual reality environment while brain signals are record...
What is the current status of trial NCT05103384?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2022-07-22. Estimated completion is 2024-06-24.
What interventions are being tested in trial NCT05103384?
The interventions under investigation include: Virtual Reality Environment (OTHER).
Who is sponsoring clinical trial NCT05103384?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI